Walleye Trading’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Walleye Trading’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,528	Closed	-$800K	–	5582
2023 Q4	$800K	Buy	+2,528	New	+$491K	﹤0.01%	2669
2023 Q2	–	Sell	-1,862	Closed	-$399K	–	5333
2023 Q1	$338K	Sell	1,862 -4,709	-72%	-$901K	﹤0.01%	3125
2022 Q4	$1.29M	Buy	6,571 +3,213	+96%	+$689K	﹤0.01%	2023
2022 Q3	$755K	Sell	3,358 -3,865	-54%	-$782K	﹤0.01%	2509
2022 Q2	$914K	Buy	7,223 +5,364	+289%	+$616K	﹤0.01%	2310
2022 Q1	$236K	Buy	+1,859	New	+$209K	﹤0.01%	3653

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Walleye Trading's KRTX Position: Q1 2024 in Review

Walleye Trading sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,528 shares — an estimated $800K sold.

Walleye Trading first reported a position in KRTX in Q1 2022 and held it in 6 quarters. The position peaked at $1.29M in Q4 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Walleye Trading reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Walleye Trading sold 2,528 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $800K.
Walleye Trading first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
Walleye Trading's Karuna Therapeutics, Inc. Common Stock position peaked at $1.29M in Q4 2022.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.